Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

US-friendly broker Finpari

 

Enter Stock Symbol:  

Peregrine Pharma New (PPHM)

0.7057 +0.0293 (+4.3318%)

3/24/2017  4:00pm

Open:

0.6792

Pre. Close:

0.6764

High:

0.7199

Low:

0.6576

Volume:

3,038,526

Market Cap:

210.09M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

0.73 - 0.75

0.75 - 0.77

Low:

0.64 - 0.64

0.64 - 0.65

Close:

0.7 - 0.71

0.71 - 0.74

Technical analysis  (as of: 2017-03-24 4:37:45 PM)

Overall:

      

Stoxline posted a NEUTRAL today, upgraded from lower rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.

Target:

Six months: 0.90     One year: 1.05

Support:

Support1: 0.57    Support2: 0.45

Resistance:

Resistance1: 0.77    Resistance2: 0.90

Pivot:

0.69

Moving Averages:

MA(5): 0.70     MA(20): 0.68

MA(100): 0.40     MA(250): 0.39

MACD:

MACD(12,26): 0.06     Signal(12,26,9): 0.07

%K %D:

%K(14,3): 59.97     %D(3): 63.45

RSI:

RSI(14): 62.05

52-Week:

High: 0.7740  Low: 0.2820  Change(%): 76.4

Average Vol(K):

3-Month: 3921  10-Days 3283

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
PPHM has closed below upper band by 39.7%. Bollinger Bands are 3.5% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Thu, 23 Mar 2017 11:03:45 GMT
Peregrine Pharmaceuticals Announces Five Abstracts Accepted for Presentation ...

Tue, 14 Mar 2017 00:12:50 GMT
Peregrine Pharmaceuticals' (PPHM) CEO Steve King on Q3 2017 Results - Earnings ...

Thu, 09 Mar 2017 11:26:15 GMT
Today's Research Reports on Trending Biotech Tickers: Peregrine ...

Thu, 02 Mar 2017 22:25:43 GMT
Ronin Capital Shows New 6.8% Stake in Peregrine Pharmaceuticals (PPHM) - 13D

Mon, 06 Mar 2017 14:09:06 GMT
Peregrine Pharmaceuticals (NASDAQ:PPHM) Is One To Watch Ahead Of Earnings

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biopharmaceuticals

Shares Out. (M)

257.14

Shares Float (M)

241.89

% Held by Insiders

4.45

% Held by Institutions

17.60

Shares Short (K)

4250

Shares Short Prior Month (K)

634

Stock Financials

EPS

-0.160

EPS Est. Current Year

EPS Est. Next Year

EPS Est. Next Quarter

Forward EPS

Book Value (p.s.)

0.150

PEG Ratio

Profit Margin

-59.43

Operating Margin

-59.60

Return on Assets (ttm)

-18.9

Return on Equity (ttm)

-69.6

Qtrly Rev. Growth

60.2

Gross Profit (p.s.)

0.084

Sales Per Share

0.228

EBITDA (p.s.)

-0.126

Qtrly Earnings Growth

Operating Cash Flow (M)

-33.23

Levered Free Cash Flow (M)

-20.70

FoxReading.com

Valuation

P/E

-4.41

P/E Growth Ratio

0.04

P/BV

4.70

P/S

3.10

P/CF

-5.46

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

0.2

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.